Jacomet C - Search Results

1

Difficulties in diagnosing group o human immunodeficiency virus type 1 acute primary infection.

Henquell C, Jacomet C, Antoniotti O, Chaib A, Regagnon C, Brunet S, Peigue-Lafeuille H, Barin F. Henquell C, et al. Among authors: jacomet c. J Clin Microbiol. 2008 Jul;46(7):2453-6. doi: 10.1128/JCM.02217-07. Epub 2008 May 14. J Clin Microbiol. 2008. PMID: 18480223 Free PMC article.

2

Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration.

Pantazis N, Sabin CA, Grabar S, Van der Valk M, Jarrin I, van Sighem A, Meyer L, Carlander C, Gill J, Volny Anne A, Spire B, Tariq S, Burns F, Costagliola D, Ruiz-Burga E, Touloumi G, Porter K; CASCADE Collaboration. Pantazis N, et al. Lancet HIV. 2024 Oct;11(10):e660-e669. doi: 10.1016/S2352-3018(24)00183-8. Epub 2024 Aug 23. Lancet HIV. 2024. PMID: 39186940

3

Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial.

Mazouz F, Bertine M, Coppée R, Storto A, Katlama C, Landman R, Cabié A, Peytavin G, Raffi F, Yazdanpanah Y, Descamps D, Joly V, Ghosn J, Charpentier C; LAMIDOL Study Group. Mazouz F, et al. J Antimicrob Chemother. 2023 Dec 1;78(12):2995-3002. doi: 10.1093/jac/dkad344. J Antimicrob Chemother. 2023. PMID: 37930812 Clinical Trial.

4

Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).

Rozenberg S, Lanoy E, Bentata M, Viard JP, Valantin MA, Missy P, Darasteanu I, Roux C, Kolta S, Costagliola D; ANRS 120 Fosivir Study Group. Rozenberg S, et al. AIDS Res Hum Retroviruses. 2012 Sep;28(9):972-80. doi: 10.1089/AID.2011.0224. Epub 2012 Mar 23. AIDS Res Hum Retroviruses. 2012. PMID: 22353022 Clinical Trial.

5

Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in France.

Tetart M, Passecountrin P, Lesourd A, Sanderink D, Le Moal G, Surgers L, Beraud G, Katlama C, Robineau O, Parienti JJ; COMEDWEEK Study group. Tetart M, et al. J Antimicrob Chemother. 2023 Nov 6;78(11):2731-2734. doi: 10.1093/jac/dkad292. J Antimicrob Chemother. 2023. PMID: 37757452

6

Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients.

Marceau G, Sapin V, Jacomet C, Ughetto S, Cormerais L, Regagnon C, Dastugue B, Peigue-Lafeuille H, Beytout J, Laurichesse H. Marceau G, et al. Among authors: jacomet c. Clin Chem. 2003 Jul;49(7):1154-62. doi: 10.1373/49.7.1154. Clin Chem. 2003. PMID: 12816913

7

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.

Marcelin AG, Delaugerre C, Beaudoux C, Descamps D, Morand-Joubert L, Amiel C, Schneider V, Ferre V, Izopet J, Si-Mohamed A, Maillard A, Henquell C, Desbois D, Lazrek M, Signori-Schmuck A, Rogez S, Yerly S, Trabaud MA, Plantier JC, Fourati S, Houssaini A, Masquelier B, Calvez V, Flandre P; ANRS AC11 Resistance Group. Marcelin AG, et al. Int J Antimicrob Agents. 2013 Jul;42(1):42-7. doi: 10.1016/j.ijantimicag.2013.02.016. Epub 2013 Apr 4. Int J Antimicrob Agents. 2013. PMID: 23562640

8

Transmitted drug resistance in French HIV-2-infected patients.

Charpentier C, Visseaux B, Bénard A, Peytavin G, Damond F, Roy C, Taieb A, Chêne G, Matheron S, Brun-Vézinet F, Descamps D; ANRS CO5 HIV-2 Cohort. Charpentier C, et al. AIDS. 2013 Jun 19;27(10):1671-4. doi: 10.1097/QAD.0b013e32836207f3. AIDS. 2013. PMID: 23595155

9

Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.

Frange P, Meyer L, Jung M, Goujard C, Zucman D, Abel S, Hochedez P, Gousset M, Gascuel O, Rouzioux C, Chaix ML; ANRS PRIMO Cohort Study Group. Frange P, et al. PLoS One. 2013 Jul 9;8(7):e69144. doi: 10.1371/journal.pone.0069144. Print 2013. PLoS One. 2013. PMID: 23874894 Free PMC article.

10

Addressing the challenges of chronic viral infections and addiction in prisons: the PRODEPIST study.

Jacomet C, Guyot-Lénat A, Bonny C, Henquell C, Rude M, Dydymski S, Lesturgeon JA, Lambert C, Pereira B, Schmidt J. Jacomet C, et al. Eur J Public Health. 2016 Feb;26(1):122-8. doi: 10.1093/eurpub/ckv183. Epub 2015 Oct 9. Eur J Public Health. 2016. PMID: 26454876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters